A
ISSUER//CIK 0001836056
Ambrx Biopharma Cayman, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Cayman Islands
Recent Filings
- SC 13G/A132.4 KBAmbrx Biopharma Cayman, Inc.Feb 9, 5:08 PM ET·0001193125-24-030277
- 8-K553.4 KBAmbrx Biopharma Cayman, Inc.Oct 12, 6:04 AM ET·0001193125-23-254549
- 8-K225.2 KBAmbrx Biopharma Inc.Oct 10, 4:49 PM ET·0001193125-23-253527
- SC 13G53.6 KBAmbrx Biopharma Inc.Oct 10, 11:35 AM ET·0001140361-23-047537
- 8-K218.0 KBAmbrx Biopharma Inc.Oct 6, 4:07 PM ET·0000950170-23-052396
- SC 13G77.8 KBAmbrx Biopharma Inc.Sep 25, 5:24 PM ET·0001104659-23-103570
- 8-K233.8 KBAmbrx Biopharma Inc.Sep 22, 5:36 PM ET·0000950170-23-049468
- 8-K270.7 KBAmbrx Biopharma Inc.Sep 15, 4:24 PM ET·0001193125-23-236202
- 8-K235.4 KBAmbrx Biopharma Inc.Sep 6, 4:05 PM ET·0000950170-23-046718
- 8-K236.6 KBAmbrx Biopharma Inc.Aug 25, 5:23 PM ET·0000950170-23-044643
Insiders
10- Aromando AndrewChief Operating Officer
- Chang XiaoweiDirector
- Chen Bihua10% Owner
- Commodore Capital LP10% Owner
- Cormorant Asset Management, LP10% Owner
- Cormorant Private Healthcare Fund III LP10% Owner
- DALESANDRO MARGARETDirector
- Darwin Global Management, Ltd.10% Owner
- Darwin Global Master Fund, Ltd.10% Owner
- Glover Stephen C.Director
Tickers
No tickers on record
Addresses
business
10975 NORTH TORREY PINES ROAD
LA JOLLA, CA, 92037
mailing
10975 NORTH TORREY PINES ROAD
LA JOLLA, CA, 92037
Former Names
- Ambrx Biopharma Inc.2023-10-10